Search
NextCure Inc
NXTCAdd to Watchlist
1.600USD
-0.150-8.57%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
5.78MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-30The current earnings forecast score of NextCure Inc is 8.67, ranking 70 out of 387 in the Biotechnology & Medical Research industry. The average price target is 18.00, with a high of 20.00 and a low of 15.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
17.667
Target Price
+909.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
NextCure Inc
NXTC
3
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is NextCure Inc's price target?
Analysts forecast that NextCure Inc's price target is USD 18.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 15.00.
How have NextCure IncNXTC's recent earnings per share performed?
The market expectation was USD -1.87, while NextCure IncNXTC's earnings per share (EPS) for the previous quarter was USD -2.37. EPS for the next quarter is expected at USD -1.93.
What is the analyst rating for NextCure Inc?
Based on the ratings of NextCure Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.